Private Equity

The infant nutrition giant is entering Canada's booming organic market, betting on brand trust to compete in an increasingly crowded and conscious space.

For millions suffering from relentless chronic cough with no approved treatments, Trevi Therapeutics' Haduvio offers a new possibility backed by strong clinical data.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

In a deal highlighting intense focus on supply chain resilience, J.F. Lehman acquires critical forgings provider Forged Solutions Group from Arlington Capital.

Avenacy launches its 26th product, a generic Benadryl injection, tackling drug shortages and aiming to improve patient safety with unique packaging.

After a dramatic pivot and massive fundraising, Galecto will detail its new hematology pipeline at a key conference. Here’s what investors are watching.

UroGen's new bladder cancer drug sees rapid uptake post-reimbursement code, but a $153M loss and fresh debt highlight its high-stakes growth strategy.

As its Reliquias mine restart nears, Silver Mountain launches a major drill campaign at Caudalosa, aiming to capitalize on a bullish silver market.

Manhattan's top landlord promotes Harrison Sitomer from intern to President, signaling a focus on stability as it navigates a complex office market.

The healthcare firm reports a 56% revenue surge to $3.2B, but a "material weakness" in financial controls and a delayed SEC filing cast a shadow.

Industry legend William Sheriff moves to Verdera Energy, unlocking a major New Mexico uranium portfolio in a strategic spin-out from giant enCore Energy.

Private equity giant Warburg Pincus invests up to $1 billion in Global Eggs, fueling a rapid consolidation of the world's protein supply.

A new partnership between Japan's Marubeni and US firm Branford Castle promises to reshape the lower middle-market, offering small businesses global reach.

Riding record gold prices, TRX Gold shatters production records and cleans its balance sheet, fast-tracking a major expansion at its Buckreef project.

Zymeworks lands $250M from Royalty Pharma in a non-dilutive deal, validating its cancer drug Ziihera and highlighting a new era of biotech financing.

With positive Phase 3 data for its first-in-class Stargardt disease drug and a massive new financing round, Belite Bio pivots toward commercialization.

Clean Freak Car Wash enters the Minnesota market with a Holiday partnership, offering fuel savings and escalating competition in an already crowded local industry.

Argo Biopharma's new CFO/CSO, Dr. Gena Wang, leaves a star analyst career at Barclays, signaling a major validation for the company's siRNA platform.

With a 33% revenue surge, Orezone Gold is funding a transformative expansion into Canada, diversifying away from its core West African operations.

RIB Software's virtual event will gather global experts to explore how AI and connected data are tackling fragmentation and reshaping the AEC industry.